Complex Regional Pain Syndrome clinical trials at UCSF
1 in progress, 1 open to new patients
open to eligible people ages 22-75
The purpose of this prospective, multicenter, single arm post-approval study is to demonstrate continued safety of the Axium Neurostimulator System for dorsal root ganglion (DRG) stimulation. The primary endpoint is the 12-month serious adverse event rate for permanent implants.
San Francisco, California and other locations